Lista de obras -

Critical Aspects of Clinical Trial Design for Novel Cell and Gene Therapies ⬇️

artículo científico publicado el 27 de diciembre de 2011

Deep brain stimulation as a treatment for chorea-acanthocytosis

artículo científico publicado en 2012

Deep brain stimulation for Gilles de la Tourette syndrome: a case series targeting subregions of the globus pallidus internus

artículo científico publicado en 2011

Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration

Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease

artículo científico publicado en 2013

Exenatide and the treatment of patients with Parkinson's disease

artículo científico publicado en 2013

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

artículo científico publicado en 2017

Gender differences in quality of life following subthalamic stimulation for Parkinson's disease.

artículo científico publicado en 2013

Genotype and phenotype in Parkinson's disease: lessons in heterogeneity from deep brain stimulation

artículo científico publicado en 2013

In a rush to decide: deep brain stimulation and dopamine agonist therapy in Parkinson's disease

artículo científico publicado en 2014

Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach

artículo científico publicado en 2014

MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety.

artículo científico publicado en 2010

MRI-guided subthalamic nucleus deep brain stimulation without microelectrode recording: can we dispense with surgery under local anaesthesia?

artículo científico publicado en 2011

Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease

artículo científico publicado en 2014

Parkinson's disease, insulin resistance and novel agents of neuroprotection

artículo científico publicado en 2013

Predictive factors of speech intelligibility following subthalamic nucleus stimulation in consecutive patients with Parkinson's disease

artículo científico publicado en 2014

Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients

artículo científico publicado en 2018

Short and long term outcome of bilateral pallidal stimulation in chorea-acanthocytosis

artículo científico publicado en 2013

The surgical anatomy of the pedunculopontine nucleus cannot be disputed, buried or exhumed

Uncertainty, misunderstanding and the pedunculopontine nucleus

Understanding and Prevention of “Therapy-” Induced Dyskinesias ⬇️

artículo científico publicado el 23 de mayo de 2012

Urinary incontinence following deep brain stimulation of the pedunculopontine nucleus

artículo científico publicado en 2011

Use of e-mail for Parkinson's disease consultations: Are answers just a clic away?

artículo científico publicado en 2016

Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes

artículo científico publicado en 2010

Lista de obras de

Critical Aspects of Clinical Trial Design for Novel Cell and Gene Therapies ⬇️

Deep brain stimulation as a treatment for chorea-acanthocytosis

Deep brain stimulation for Gilles de la Tourette syndrome: a case series targeting subregions of the globus pallidus internus

Differences in MDS-UPDRS Scores Based on Hoehn and Yahr Stage and Disease Duration

Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease

Exenatide and the treatment of patients with Parkinson's disease

Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial

Gender differences in quality of life following subthalamic stimulation for Parkinson's disease.

Genotype and phenotype in Parkinson's disease: lessons in heterogeneity from deep brain stimulation

In a rush to decide: deep brain stimulation and dopamine agonist therapy in Parkinson's disease

Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson's disease using an MRI-guided and MRI-verified approach

MRI-guided STN DBS in Parkinson's disease without microelectrode recording: efficacy and safety.

MRI-guided subthalamic nucleus deep brain stimulation without microelectrode recording: can we dispense with surgery under local anaesthesia?

Motor and cognitive advantages persist 12 months after exenatide exposure in Parkinson's disease

Parkinson's disease, insulin resistance and novel agents of neuroprotection

Predictive factors of speech intelligibility following subthalamic nucleus stimulation in consecutive patients with Parkinson's disease

Relationship between the MDS-UPDRS and Quality of Life: A large multicenter study of 3206 patients

Short and long term outcome of bilateral pallidal stimulation in chorea-acanthocytosis

The surgical anatomy of the pedunculopontine nucleus cannot be disputed, buried or exhumed

Uncertainty, misunderstanding and the pedunculopontine nucleus

Understanding and Prevention of “Therapy-” Induced Dyskinesias ⬇️

Urinary incontinence following deep brain stimulation of the pedunculopontine nucleus

Use of e-mail for Parkinson's disease consultations: Are answers just a clic away?

Which patients with dystonia benefit from deep brain stimulation? A metaregression of individual patient outcomes